Beta2-adrenergic System and Training

University of Copenhagen

Status: Unknown

Conditions: Healthy

Treatments: Behavioral: Training; Drug: Formoterol; Drug: Placebo

Study type: Interventional

Funder types: Other

Identifiers

NCT04616261

FOREX

Details and patient eligibility

About

This project aims to examine the trainability of the beta2-adrenergic system with respect to the individual performance response

Enrollment: 30 estimated patients

Sex: Male

Ages: 18 to 45 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• 18 to 45 years of age
• Trained individuals with a maximal oxygen uptake above 55 ml/min/kg
• Body mass index lower than 26

Exclusion criteria

• Allergy towards study drug
• Unacceptable side effects to the study drug
• Chronic disease deemed by the MD to interfere with the study
• Smoking
• Use of prescription medicine

Trial design

Primary purpose: Basic Science

Allocation: Randomized

Interventional model: Factorial Assignment

Masking: Triple Blind

---

30 participants in 2 patient groups

SET-HIGH

Experimental group

Description:

High volume speed endurance training

Treatment:

Drug: Placebo

Drug: Formoterol

Behavioral: Training

SET-LOW

Experimental group

Description:

Low volume speed endurance training

Treatment:

Drug: Placebo

Drug: Formoterol

Behavioral: Training